Aleafia Health Inc (AH.CA) Stock Fundamental Analysis

TSX:AH • CA01444Q1046

0.02 CAD
0 (0%)
Last: Jul 25, 2023, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall AH gets a fundamental rating of 2 out of 10. We evaluated AH against 33 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of AH have multiple concerns. AH shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AH has reported negative net income.
  • In the past year AH has reported a negative cash flow from operations.
  • In the past 5 years AH always reported negative net income.
  • AH had a negative operating cash flow in each of the past 5 years.
AH.CA Yearly Net Income VS EBIT VS OCF VS FCFAH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

  • The profitability ratios for AH are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AH.CA Yearly ROA, ROE, ROICAH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

1.3 Margins

  • AH has a Gross Margin of 21.35%. This is comparable to the rest of the industry: AH outperforms 44.19% of its industry peers.
  • AH's Gross Margin has declined in the last couple of years.
  • AH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-52.06%
GM growth 5Y-25.49%
AH.CA Yearly Profit, Operating, Gross MarginsAH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • AH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AH has been increased compared to 1 year ago.
  • The debt/assets ratio for AH is higher compared to a year ago.
AH.CA Yearly Shares OutstandingAH.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
AH.CA Yearly Total Debt VS Total AssetsAH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

  • AH has an Altman-Z score of -12.50. This is a bad value and indicates that AH is not financially healthy and even has some risk of bankruptcy.
  • AH's Altman-Z score of -12.50 is on the low side compared to the rest of the industry. AH is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.5
ROIC/WACCN/A
WACC4.33%
AH.CA Yearly LT Debt VS Equity VS FCFAH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

  • AH has a Current Ratio of 0.83. This is a bad value and indicates that AH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of AH (0.83) is worse than 74.42% of its industry peers.
  • A Quick Ratio of 0.22 indicates that AH may have some problems paying its short term obligations.
  • AH's Quick ratio of 0.22 is on the low side compared to the rest of the industry. AH is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.22
AH.CA Yearly Current Assets VS Current LiabilitesAH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 79.40% over the past year.
  • AH shows a strong growth in Revenue. In the last year, the Revenue has grown by 52.19%.
  • AH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.75% yearly.
EPS 1Y (TTM)79.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.84%
Revenue 1Y (TTM)52.19%
Revenue growth 3Y37.87%
Revenue growth 5Y61.75%
Sales Q2Q%33.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.32% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 31.85% on average over the next years. This is a very strong growth
EPS Next Y40%
EPS Next 2Y18.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year51.58%
Revenue Next 2Y31.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AH.CA Yearly Revenue VS EstimatesAH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AH.CA Yearly EPS VS EstimatesAH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • AH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AH.CA Price Earnings VS Forward Price EarningsAH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AH.CA Per share dataAH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

  • AH's earnings are expected to grow with 18.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.32%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Aleafia Health Inc

TSX:AH (7/25/2023, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.06%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.06M
Revenue(TTM)54.88M
Net Income(TTM)-39.08M
Analysts40
Price Target0.15 (650%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.41%
Min Revenue beat(2)-38.79%
Max Revenue beat(2)-20.04%
Revenue beat(4)1
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-38.79%
Max Revenue beat(4)92.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.14
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-52.06%
GM growth 5Y-25.49%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.19%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.22
Altman-Z -12.5
F-Score4
WACC4.33%
ROIC/WACCN/A
Cap/Depr(3y)79.73%
Cap/Depr(5y)248.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.84%
EPS Next Y40%
EPS Next 2Y18.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.19%
Revenue growth 3Y37.87%
Revenue growth 5Y61.75%
Sales Q2Q%33.46%
Revenue Next Year51.58%
Revenue Next 2Y31.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y66.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.35%
OCF growth 3YN/A
OCF growth 5YN/A

Aleafia Health Inc / AH.CA FAQ

What is the ChartMill fundamental rating of Aleafia Health Inc (AH.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AH.CA.


What is the valuation status for AH stock?

ChartMill assigns a valuation rating of 0 / 10 to Aleafia Health Inc (AH.CA). This can be considered as Overvalued.


How profitable is Aleafia Health Inc (AH.CA) stock?

Aleafia Health Inc (AH.CA) has a profitability rating of 0 / 10.


How financially healthy is Aleafia Health Inc?

The financial health rating of Aleafia Health Inc (AH.CA) is 0 / 10.